Differential effects of radiation fractionation regimens on glioblastoma

BACKGROUND: Radiotherapy (RT) is a mainstay of treatment for patients with glioblastoma (GB). Early clinical trials show that short course hypofractionation showed no survival benefit compared to conventional regimens with or without temozolomide chemotherapy (TMZ) but reduces the number of doses re...

Descripción completa

Detalles Bibliográficos
Autores principales: McKelvey, Kelly J., Hudson, Amanda L., Donaghy, Heather, Stoner, Shihani P., Wheeler, Helen R., Diakos, Connie I., Howell, Viive M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788072/
https://www.ncbi.nlm.nih.gov/pubmed/35073960
http://dx.doi.org/10.1186/s13014-022-01990-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788072/
https://www.ncbi.nlm.nih.gov/pubmed/35073960
http://dx.doi.org/10.1186/s13014-022-01990-y

Ejemplares similares